<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Partial deletion of chromosome 5q (5q-) is a frequent aberration in <z:hpo ids='HP_0002863'>myelodysplasias</z:hpo> and <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It causes clinical and hematological symptoms termed the <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q-syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Although more than 30 different 5q deletions are described, recent studies have demonstrated 5q31 as the common deleted region and have mapped a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor (IRF-1) and a cluster of interleukin genes to 5q31 </plain></SENT>
<SENT sid="3" pm="."><plain>Furthermore, del(5)(q13q33) is associated with longer survival, which means that 5q segments other than 5q31 also are of importance </plain></SENT>
<SENT sid="4" pm="."><plain>These data suggest that loss of the suppressor releases the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e>, interleukin losses determine the hematology and deletion of other 5q segments affect survival </plain></SENT>
</text></document>